4-[(1R,3aS,4R,6aS)-4-(4-Hydroxy-3,5-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2,6-dimethoxyphenyl 2-O-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranos ide(CAS: 136997-64-3)

The compound requires compliance with GHS classification for hazardous substances, REACH regulations for registration, evaluation, authorization, and restriction of chemicals, and FDA/EPA guidelines for handling, storage, and disposal. Specific regulations may vary based on the intended use and jurisdiction.

Alternatives include analogous compounds with similar functional groups, using isomers, or employing different reagents such as 2-O-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranosides of other phenols. Specific alternatives depend on the synthetic route and desired properties.

Research trends indicate growing interest in natural product analogs and glycosides for medicinal and pharmaceutical applications. Market trends suggest increasing demand due to their potential in drug discovery and personalized medicine. However, further studies are needed to establish their efficacy and safety.

Waste should be collected in appropriate containers and disposed of by incineration or professionally managed waste disposal services. Ensure proper handling to prevent environmental contamination, and follow local regulations for hazardous waste management. Protective measures such as gloves and goggles should be used during handling.